Betacid lotion

Maa: Armenia

Kieli: englanti

Lähde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktiivinen ainesosa:

betamethasone (betamethasone dipropionate), salicylic acid

Saatavilla:

Arpimed LLC

ATC-koodi:

D07XC01

INN (Kansainvälinen yleisnimi):

betamethasone (betamethasone dipropionate), salicylic acid

Annos:

0,5mg/ml+ 20mg/ml

Lääkemuoto:

lotion

Kpl paketissa:

30ml glass bottle

Prescription tyyppi:

Prescription

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2023-10-12

Valmisteyhteenveto

SUMMARY OF PRODUCT CHARACTERISTICS (SPC)
1. NAME OF THE MEDICAL PRODUCT
Betacid 0.5/20mg/ml lotion
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE INGREDIENTS:_ _0.5 mg/ml Betamethasone (as dipropionate) and 20
mg/ml Salicylic acid_ _
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Lotion. A transparent, colorless and odorless liquid.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Betamethasone Dipropionate is a synthetic fluorinated corticosteroid.
It is active topically and
produces a rapid and sustained response in those inflammatory
dermatoses that are normally
responsive to topical corticosteroid therapy, and it is also effective
in the less responsive conditions,
such as psoriasis of the scalp.
Topical salicylic acid softens keratin, loosens cornified epithelium
and desquamates the epidermis.
Betacid lotion are therefore indicated for the treatment of
hyperkeratotic and dry corticosteroid-
responsive dermatoses where the cornified epithelium may resist
penetration of the steroid. The
salicylic acid constituent of Betacid lotion, as a result of its
descaling action, allows access of the
dermis more rapidly than by applying steroid alone.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
Adults:
Once to twice daily. In most cases a thin film should be applied to
the affected areas twice daily and
massaged gently and thoroughly into the skin.
For some patients adequate maintenance therapy may be achieved with
less frequent application.
It is recommended that Betacid lotion are prescribed for two weeks,
and that treatment is reviewed
at that time. The maximum weekly dose should not exceed 60g.
Children:
Dosage in children should be limited to 5 days.
4.3 CONTRAINDICATIONS
Rosacea, acne, perioral dermatitis, perianal and genital pruritus.
Hypersensitivity to any of the
ingredients of the Betacid lotion contra-indicates their use as does
tuberculous and most viral lesions
of the skin, particularly herpes simplex, vacinia, varicella. Betacid
should not be used in na